After adjusting for potential confounders (age, sex, race, use of birth control, pregnancy), findings showed propranolol use was associated with a significant reduction in the risk of stroke among ...

The Food and Drug Administration (FDA) has approved Symbravo ® (meloxicam/rizatriptan) for the acute treatment of migraine with or without aura in adults.

Propranolol is associated with a reduced risk for overall stroke among women with migraine, with a more pronounced protective effect for ischemic stroke.

The US Food and Drug Administration has approved Symbravo (meloxicam and rizatriptan) for the acute treatment of migraine with or without aura in adults.

Epidemiology Forecast to 2033" report has been added to ResearchAndMarkets.com's offering.In the 7MM, the 12-month total prevalent cases of migraine are expected to increase from 74,226,117 cases in ...

But understanding what happens in your brain during an attack can help manage the condition better and empower them. A ...

Discover effective supplements for migraine prevention and learn who should or shouldn't use them. Explore evidence-based ...

A common blood pressure medication used to prevent migraines may also significantly reduce the risk of ischemic stroke in women, according to a new study. The research, presented at the American ...

Axsome Therapeutics, Inc. (NASDAQ:AXSM) signed a settlement agreement with Teva Pharmaceuticals Inc (NYSE:TEVA). The ...

Headache with the features of migraine without aura usually follows the aura symptoms. Less commonly, headache lacks migrainous features or is completely absent. Previously it was called classic ...

Research analysts at StockNews.com initiated coverage on shares of Tonix Pharmaceuticals (NASDAQ:TNXP – Get Free Report) in a research note issued to investors on Monday. The brokerage set a “sell” ...